Bookbuilding IPO | ₹14 Cr | Listed at NSE SME | Mon, Aug 7, 2017 - Thu, Aug 10, 2017
Vaishali Pharma IPO is a book build issue of ₹14.23 crores. The issue is entirely a fresh issue of 0.20 crore shares of ₹14.23 crore.
Vaishali Pharma IPO bidding started from Aug 7, 2017 and ended on Aug 10, 2017. The shares got listed on the NSE SME on Aug 22, 2017.
Vaishali Pharma IPO is set final issue price at ₹72 per share. The lot size for an application is 1,600 shares. The minimum amount of investment required by an individual investor (retail) is ₹1,15,200 (1600 shares) (based on upper price). The minimum lot size for investment in HNI is 2 lots (3,200 shares), amounting to ₹2,30,400.
Pantomath Capital Advisors Pvt.Ltd. is the book running lead manager and Bigshare Services Pvt.Ltd. is the registrar of the issue. The Market Maker of the company is Pantomath Stock Brokers Pvt.Ltd.
Refer to Vaishali Pharma IPO RHP for detailed Information.
IPO Open
Mon, Aug 7, 2017
IPO Close
Thu, Aug 10, 2017
Issue Price
₹72 per share
Market Cap (Pre-IPO)
₹47.46 Cr
| IPO Date | 7 to 10 Aug, 2017 |
| Listed on | Tue, Aug 22, 2017 |
| Face Value | ₹10 per share |
| Price Band | ₹71 to ₹72 |
| Issue Price | ₹72 per share |
| Lot Size | 1,600 Shares |
| Sale Type | Fresh capital only |
| Issue Type | Bookbuilding IPO |
| Listing At | NSE SME |
| Total Issue Size | 19,76,000 shares (agg. up to ₹14 Cr) |
| Reserved for Market Maker | 1,04,000 shares Pantomath Stock Brokers Pvt.Ltd. (agg. up to ₹0.7488 Cr) |
| Fresh Issue (Ex Market Maker) | 18,72,000 shares (agg. up to ₹13 Cr) |
| Net Offered to Public | 18,72,000 shares (agg. up to ₹13 Cr) |
| Share Holding Pre Issue | 46,15,385 shares |
| Share Holding Post Issue | 65,91,385 shares |
| NSE Symbol | VAISHALI |
| ISIN | INE972X01022 |
Vaishali Pharma IPO comprises a total issue size of 19,76,000 shares. The net offer to the public is 18,72,000 shares, after excluding 1,04,000 shares allotted on a firm basis. Of the Net offer 9,36,000 (50.00%) allocated to NII 9,36,000 (50.00%) allocated to RII.
| Investor Category | Shares Offered | % of Net Issue | % of Total Issue |
|---|---|---|---|
| NII (HNI) Shares Offered | 9,36,000 | 50.00% | 47.37% |
| Retail Shares Offered | 9,36,000 | 50.00% | 47.37% |
| Firm Reservations | |||
| Market Maker Shares Offered | 1,04,000 | 5.26% | |
| Total Shares Offered | 19,76,000 | 100.00% | 100.00% |
Investors can bid for a minimum of 1,600 shares and in multiples thereof.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 1,600 | ₹1,15,200 |
| Retail (Max) | 1 | 1,600 | ₹1,15,200 |
| HNI (Min) | 2 | 3,200 | ₹2,30,400 |
Incorporated in 2008, Vaishali Pharma Ltd is a pharmaceutical company engaged in pharmaceutical formulations, APIs, surgical products, veterinary supplements, herbal & nutraceutical products. They are operating both in domestic and export markets. They have also established office in the Vietnam. At present they are supplying in around 10 countries.
In domestic markets, they are majorly into trading of APIs whereas in export markets, they are into trading and marketing of APIs, formulations, surgical products and others. Recently they have applied for 186 registrations in 13 countries for some of their products and received 71 approvals from 7 countries.
They export Formulations, Surgical & APIs to Kenya, Sri Lanka, Russia, DR Congo, Myanmar, Tajikistan, Bangladesh, Kazakhstan, Cameroon, Jordan, Burkina -Faso, Nicaragua, Senegal, Pakistan, Ukraine, Yemen, Cambodia, Turkey, Congo, Zimbabwe, Ethiopia, Tanzania, Vietnam, Armenia, Costa Rica, Nigeria, C.A.R. and Guinea-Bissau.
| Company | Issue Type | Issue Size | Issue Price | PE Ratio | Listing Day Close | Listing Gain/Loss % | LTP |
|---|---|---|---|---|---|---|---|
| Zota Health Care Ltd. | SME | ₹58.50 Cr | ₹125 | null | ₹125.60 | +0.48% | ₹1,349.70 (-1.48%) |
| Sakar Healthcare Ltd. | SME | ₹14.81 Cr | ₹50 | null | ₹52.15 | +4.30% | ₹877.70 (-2.15%) |
| Eris Lifesciences Ltd. | Mainboard | ₹1,740.49 Cr | ₹603 | null | ₹601.50 | -0.25% | ₹1,455.40 (-2.44%) |
| Laurus Labs Ltd. | Mainboard | ₹1,330.51 Cr | ₹428 | null | ₹480.40 | +12.24% | ₹1,529.80 (-1.79%) |
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Working Capital Requirement | 13.00 |
| 2 | General corporate purposes | 0.63 |
The Vaishali Pharma IPO IPO subscription status. Full data available on IPOMatrix.com.
| Category | Subscription (times) | Shares Offered | Shares bid for | Total Applications |
|---|---|---|---|---|
| Total | 1.60 | 18,72,000 | 29,92,000 | 1,209 |
| # | Issue Expenses | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Payment to Merchant Banker including expenses towards printing, advertising, and payment to other intermediaries such as Registrars, Bankers etc. | 0.35 |
| 2 | Regulatory fees | 0.10 |
| 3 | Marketing and Other Expenses | 0.15 |
| Price Details | NSE SME |
|---|---|
| Final Issue Price | ₹72.00 |
| Open | ₹71.90 |
| Low | ₹66.55 |
| High | ₹73.00 |
| Last Trade | ₹70.35 |
Lead Manager Reports
Vaishali Pharma IPO is a SME IPO of 19,76,000 equity shares of the face value of ₹10 aggregating up to ₹14 Crores. The issue is priced at ₹72 per share. The minimum order quantity is 1600.
The IPO opens on Mon, Aug 7, 2017, and closes on Thu, Aug 10, 2017.
Bigshare Services Pvt.Ltd. is the registrar for the IPO. The shares are proposed to be listed on NSE SME.
Zerodha customers can apply online in Vaishali Pharma IPO using UPI as a payment gateway. Zerodha customers can apply in Vaishali Pharma IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in Vaishali Pharma IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The Vaishali Pharma IPO opens on Mon, Aug 7, 2017 and closes on Thu, Aug 10, 2017.
Vaishali Pharma IPO lot size is 1600, and the minimum amount required for application is ₹1,15,200.
You can apply in Vaishali Pharma IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.
The finalization of Basis of Allotment for Vaishali Pharma IPO will be done on Wednesday, August 16, 2017, and the allotted shares will be credited to your demat account by . Check the Vaishali Pharma IPO allotment status.
The Vaishali Pharma IPO listing date is on Tue, Aug 22, 2017.
